NSE: ANURAS | BSE: 543275

Momentum Trap

Download real time

768.25 -2.40 (-0.31%)

27.83% Gain from 52W Low

479.4K NSE+BSE Volume

NSE 24 Mar, 2025 3:31 PM (IST)

8,445.5

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Anupam Rasayan India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ANURAS, BSE:543275 Anupam Rasayan India Ltd.

Anupam Rasayan India Ltd.

10 Mar 2021

768.25

-0.31%

Anupam Rasayan India Limited IPO Note 10032021

IPO Note: Anupam Rasayan India Ltd.

HDFC Securities

Anupam Rasayan India Limited IPO Note Issue Open: Mar 12 Mar 16, 2021 Price Band: Rs. 553 555 (discount of Rs.55 for eligible employees) *Issue Size: 13,693,694 eq shares (including Employee Reservation of 220,000 Eq sh) *Issue Size: Rs. 757.3 760.0 cr Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail atleast 35% eq sh

Anupam Rasayan India Ltd. has gained 20.03% in the last 1 Month

Anupam Rasayan India Ltd.

10 Mar 2021

768.25

-0.31%

Anupam Rasayan India - IPO

IPO Note: Anupam Rasayan India Ltd.

ICICI Securities Limited

To expand business by capitalising on industry opportunities, organic, inorganic growth network In 2019, the Indian market for custom synthesis and manufacturing was valued at US$11.5 billion in 2019 for specialty chemicals accounting for ~6% of the global custom synthesis and manufacturing market. Custom synthesis manufacturing is on the rise in India while the contract research and manufacturing services market is expected to grow at 12% in the next five years, owing to strong growth from end-use demand. In addition, the China...

Anupam Rasayan India Ltd. is trading above all available SMAs

Anupam Rasayan India Ltd.

10 Mar 2021

768.25

-0.31%

Anupam Rasayan India Ltd. IPO Note

IPO Note: Anupam Rasayan India Ltd.

Ashika Research

Anupam Rasayan India Ltd. (ARIL) is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India (Source: F&S; Report). The company evolved into custom synthesis and manufacturing of life science related specialty chemicals and...

Promoters pledged 2.72% of shares in last quarter. Total pledge stands at 16.47% of promoter holdings

No results found

VOTE: Is Anupam Rasayan India Ltd. worth buying?

67 Votes:

Buy 80.6%

Sell 16.42%

Hold 2.99%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf